Astegolimab (MSTT 1041A; RG 6149) 是一种人 IgG2 单克隆抗体，可通过靶向 IL-33 受体 ST2 来阻断 IL-33 信号传导。Astegolimab 具有用于慢性阻塞性肺疾病 (COPD) 研究的潜力。
| 生物活性 |
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research. |
|---|---|
| CAS号 |
2173054-79-8
|
| 中文名称 |
艾特利单抗
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Store at -20˚C |
客服小K 
客服小K
Data Sheet
